Access Bio Inc (950130) — Cash Flow Quality Index
Access Bio Inc (950130) has a Cash Flow Quality Index of -6.44x as of June 2024. Operating cash flow of ₩-9.83 Billion is below net income of ₩1.53 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Access Bio Inc cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Access Bio Inc Cash Flow Quality Index (2012–2022)
Historical Cash Flow Quality Index for Access Bio Inc across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 950130 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Access Bio Inc (2012–2022)
Year-by-year earnings quality comparison for Access Bio Inc. For live market cap and the full company financial profile, see market cap of Access Bio Inc.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 0.00x | ₩291.33 Million | ₩346.67 Billion | ▲ +15.6% |
| 2021 | 0.00x | ₩137.90 Million | ₩189.69 Billion | ▼ -99.9% |
| 2020 | 0.76x | ₩36.72 Billion | ₩48.27 Billion | ▼ -66.4% |
| 2015 | 2.26x | ₩2.87 Billion | ₩1.27 Billion | ▲ +309.1% |
| 2014 | -1.08x | ₩-2.63 Billion | ₩2.43 Billion | ▼ -634.9% |
| 2013 | 0.20x | ₩1.59 Billion | ₩7.84 Billion | ▼ -18.3% |
| 2012 | 0.25x | ₩1.85 Billion | ₩7.45 Billion | — |